REG-Zelluna ASA: Invitation to Second Quarter 2026 Results Webcast Presentation
Globe Newswire•13/08/2026•06:00 ET
0
Whiz Insights
Oslo, Norway, 13 August 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of its second quarter 2026 results on Thursday, 20 August 2026.
The presentation will be available via a live webcast on www.zelluna.com at 09:00 CEST on Thursday, 20 August 2026, and participants will be able to submit questions during the presentation. The webcast recording will remain available on the company’s website after the event.
Get started
Create a free account to read the full story.